Cargando…
Drug-Drug Interactions Between Cannabidiol and Lithium
Epidiolex(®) (Cannabidiol- CBD) is approved for epilepsy associated with Dravet syndrome (DS) and Lennox-Gastaut syndrome (LGS) in patients over 2 years of age. Common side effects include somnolence and diarrhea. Recent studies have demonstrated interactions between cannabidiol and several other an...
Autores principales: | Singh, Rani K., Dillon, Brittany, Tatum, David A., Van Poppel, Katherine C., Bonthius, Daniel J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427002/ https://www.ncbi.nlm.nih.gov/pubmed/32851114 http://dx.doi.org/10.1177/2329048X20947896 |
Ejemplares similares
-
Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023) -
Clinical implications of trials investigating drug‐drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs
por: Patsalos, Philip N., et al.
Publicado: (2020) -
Lithium: one drug, five complications
por: Zaworski, Jeremy, et al.
Publicado: (2017) -
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019) -
Hyponatremic Cognitive Dysfunction Resulting from Drug-Drug-Gene Interaction between Sertraline and Cannabidiol in an Intermediate CYP2C19 Metabolizer Patient
por: Nanan, Jade Camara, et al.
Publicado: (2022)